Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody.
Baba
Toru
T
Nakashima
Ichiro
I
Kanbayashi
Takashi
T
Konno
Masatoshi
M
Takahashi
Toshiyuki
T
Fujihara
Kazuo
K
Misu
Tatsuro
T
Takeda
Atsushi
A
Shiga
Yusei
Y
Ogawa
Hiromasa
H
Itoyama
Yasuto
Y
D000328:Adult; D051401:Aquaporin 4 / Q000276:immunology*; D001323:Autoantibodies / Q000032:analysis / Q000097:blood*; D015415:Biomarkers / Q000032:analysis / Q000097:blood; D018450:Disease Progression; D005260:Female; D006801:Humans; D007031:Hypothalamus / Q000473:pathology / Q000503:physiopathology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D047908:Intracellular Signaling Peptides and Proteins / Q000032:analysis / Q000134:cerebrospinal fluid; D008279:Magnetic Resonance Imaging; D008636:Mesencephalon / Q000473:pathology / Q000503:physiopathology; D008775:Methylprednisolone / Q000627:therapeutic use; D009290:Narcolepsy / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology*; D009471:Neuromyelitis Optica / Q000150:complications* / Q000276:immunology* / Q000473:pathology; D009479:Neuropeptides / Q000032:analysis / Q000134:cerebrospinal fluid; D015835:Ocular Motility Disorders / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D000068797:Orexins; D017286:Polysomnography; D011237:Predictive Value of Tests; D012008:Recurrence; D013116:Spinal Cord / Q000473:pathology / Q000503:physiopathology; D016896:Treatment Outcome
C496030:AQP4 protein, human; D051401:Aquaporin 4; D001323:Autoantibodies; D015415:Biomarkers; D007166:Immunosuppressive Agents; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D000068797:Orexins; D008775:Methylprednisolone